This country profile provides an overview of South Africa’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 3/100
Overall rank: Joint 33rd

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
100%
Trachoma
N/A
3.9 million people received treatment in South Africa in 2016 2.9 million people in need did not receive treatment in South Africa in 2016

South Africa recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the high coverage of soil-transmitted helminths (STH) preventive chemotherapy (PC) already achieved, implement PC for schistosomiasis alongside STH, at least for school-aged children.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

South Africa does not require mass treatment for lymphatic filariasis.

Onchocerciasis

South Africa does not require mass treatment for onchocerciasis.

Schistosomiasis

Treatment coverage remained the same at 0% in 2015 and 2016.

School-aged children needing treatment
2.55m
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

⬆️ Treatment coverage increased from 0% in 2015 to 100% in 2016.

Pre-sch and school-aged children needing treatment
3.9m
Pre-school and school-aged children receiving treatment
3.9m

Trachoma

South Africa does not require mass treatment for trachoma.